Improved downstream process design for human monoclonal antibody production

BioPharm International

Volumn 20, Issue 10 SUPPL., 2007, Pages 6-10

  Arunakumari, Alahari ^a   Wang, Jue ^b   Ferreira, Gisela ^b  

^a MEDAREX INC   (United States)

^b Medarex ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN MONOCLONAL ANTIBODY; RESIN;

ANION EXCHANGE CHROMATOGRAPHY; CELL CULTURE; CHROMATOGRAPHY; COLUMN CHROMATOGRAPHY; DIAFILTRATION; DOWNSTREAM PROCESSING; INTERMETHOD COMPARISON; MAMMAL CELL; MEMBRANE CHROMATOGRAPHY; NONHUMAN; PROTEIN PURIFICATION; REVIEW; VIRUS INACTIVATION;

EID: 36048971048     PISSN: 1542166X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (7)

1. Adamson SR. A new era in biotechnology. BioProcess International Conference. San Francisco CA; 2006 November 6-9.
2. Gottschalk U. The renaissance of protein purification. Supplement to BioPharm Int. 2006 June:8-9.
3. Sofer G, Chirica LC. Improving productivity in downstream processing. BioPharm Int. 2006 Nov 19; (11):48-55.
4. Zhou JX, Tressel T. Membrane chromatography as a robust purification system for large-scale antibody production. Supplement to BioProcess Int. 2005 Sept 3; (9):32-37.
5. Cacciuttolo MA, Arunakumari A. Scale-up considerations for biotechnology-derived products. In: Michael Levin, editor. Drugs and the pharmaceutical Sciences, Vol 157, Pharmaceutical process scale-up, 2nd ed. Chapter 5. Boca Raton, FL: CRC Press, 2006.
6. Arunakumari A. Integrating high titer cell culture processes with highly efficient purification processes for the manufacturing of human monoclonal antibodies. BioProcess International Conference. San Francisco CA; 2006 Nov 6-9.
7. Jagschies G, Grönberg A, Björkman T, Lacki K, Johansson HJ. Technical and economical evaluation of downstream processing options for monoclonal antibody (MAb) production. Supplement to BioPharm Int. 2006 June:10-19.